Article History
Received: 29 August 2018
Accepted: 8 January 2019
First Online: 8 February 2019
Ethics approval and consent to participate
: The two surveys were conducted as separate studies, each receiving ethics approval from the Tasmanian Social Science Human Research Ethics Committee (approval numbers: H001265 and H0016454, respectively). Consent was obtained by way of inference after participants read the information in their invitation letter, and then completed and returning the survey by post.
: This manuscript does not contain any individual surgeon’s data in any form (i.e. <i>consent for publication</i> is not applicable).
: CM and GP report declare no conflicts of interest. LB has received consultancy funding from Aspen Pharmacare Australia for the development of education materials related to warfarin therapy. LB has also received consultancy funding from Boehringer Ingelheim Pty Ltd. for the development of educational materials for dabigatran/atrial fibrillation and provision of expert advice regarding the optimal use of anticoagulants in the prevention of stroke.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.